Martin Schaefer
Department of Psychiatry
Charité Universitätsmedizin
Berlin
Germany
Name/email consistency: high
- Three cases of successful tryptophan add-on or monotherapy of hepatitis C and IFNalpha-associated mood disorders. Schaefer, M., Winterer, J., Sarkar, R., Uebelhack, R., Franke, L., Heinz, A., Friebe, A. Psychosomatics (2008)
- Memantine-associated reversal of clozapine-induced weight gain. Schaefer, M., Leopold, K., Hinzpeter, A., Heinz, A., Krebs, M. Pharmacopsychiatry (2007)
- Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. Schaefer, M., Hinzpeter, A., Mohmand, A., Janssen, G., Pich, M., Schwaiger, M., Sarkar, R., Friebe, A., Heinz, A., Kluschke, M., Ziemer, M., Gutsche, J., Weich, V., Halangk, J., Berg, T. Hepatology (2007)
- Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C. Schaefer, M., Schwaiger, M., Garkisch, A.S., Pich, M., Hinzpeter, A., Uebelhack, R., Heinz, A., van Boemmel, F., Berg, T. J. Hepatol. (2005)
- Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha. Schaefer, M., Horn, M., Schmidt, F., Schmid-Wendtner, M.H., Volkenandt, M., Ackenheil, M., Mueller, N., Schwarz, M.J. Brain Behav. Immun. (2004)
- Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Schaefer, M., Schmidt, F., Folwaczny, C., Lorenz, R., Martin, G., Schindlbeck, N., Heldwein, W., Soyka, M., Grunze, H., Koenig, A., Loeschke, K. Hepatology (2003)
- Neurotransmitter changes by interferon-alpha and therapeutic implications. Schaefer, M., Schwaiger, M., Pich, M., Lieb, K., Heinz, A. Pharmacopsychiatry (2003)